Process View
Any process that modulates the frequency, rate or extent of bone mineralization.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of bone mineralization"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CCR5 | chemokine (C-C motif) receptor 5 | 1.000 | Human | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.999 | Human | |
| CCL5 | chemokine (C-C motif) ligand 5 | 0.997 | Human | |
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.994 | ||
| SMAD2 | SMAD family member 2 | 0.980 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.967 | ||
| BMP2 | bone morphogenetic protein 2 | 0.961 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.928 | ||
| FSTL1 | follistatin-like 1 | 0.901 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.886 | Human | |
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.826 | ||
| ENG | endoglin | 0.813 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.805 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.716 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.689 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.666 | ||
| IFNG | interferon, gamma | 0.651 | ||
| RUNX1 | runt-related transcription factor 1 | 0.636 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.630 | Human | |
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.625 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.612 | Human | |
| TJP1 | tight junction protein 1 (zona occludens 1) | 0.560 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.558 | ||
| IL2RB | interleukin 2 receptor, beta | 0.554 | ||
| SETD8 | SET domain containing (lysine methyltransferase) 8 | 0.547 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.543 | Human | |
| GDF5 | growth differentiation factor 5 | 0.467 | Human | |
| CCL2 | chemokine (C-C motif) ligand 2 | 0.425 | Human | |
| SMAD7 | SMAD family member 7 | 0.413 | ||
| VCAN | versican | 0.345 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.314 | Human | |
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.305 | ||
| KDM2B | lysine (K)-specific demethylase 2B | 0.267 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.256 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.248 | Human | |
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.236 | Human | |
| IRF4 | interferon regulatory factor 4 | 0.232 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.224 | Human | |
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.215 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.215 | ||
| IL10 | interleukin 10 | 0.214 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.211 | ||
| CCR2 | chemokine (C-C motif) receptor 2 | 0.209 | Human | |
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.189 | ||
| BMP4 | bone morphogenetic protein 4 | 0.187 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.185 | Human | |
| CCL11 | chemokine (C-C motif) ligand 11 | 0.183 | Human | |
| TM4SF1 | transmembrane 4 L six family member 1 | 0.181 | ||
| GATA2 | GATA binding protein 2 | 0.174 | ||
| SPRR2A | small proline-rich protein 2A | 0.174 | ||
| COL11A2 | collagen, type XI, alpha 2 | 0.158 | ||
| SMAD1 | SMAD family member 1 | 0.156 | ||
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.138 | Human | |
| PTPRA | protein tyrosine phosphatase, receptor type, A | 0.130 | ||
| MAFA | v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) | 0.124 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.122 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.121 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.119 | ||
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.111 | ||
| NOG | noggin | 0.106 | ||
| MAP1LC3A | microtubule-associated protein 1 light chain 3 alpha | 0.105 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.105 | ||
| ARRDC3 | arrestin domain containing 3 | 0.103 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.090 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.089 | ||
| IL1B | interleukin 1, beta | 0.086 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.086 | ||
| CD40LG | CD40 ligand | 0.083 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.082 | ||
| PRKAR1A | protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) | 0.081 | ||
| IL8 | interleukin 8 | 0.080 | ||
| EP300 | E1A binding protein p300 | 0.076 | ||
| SLAMF7 | SLAM family member 7 | 0.075 | ||
| GABARAPL2 | GABA(A) receptor-associated protein-like 2 | 0.073 | ||
| ACVR1 | activin A receptor, type I | 0.073 | ||
| CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.069 | Human | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.069 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.068 | ||
| MATK | megakaryocyte-associated tyrosine kinase | 0.067 | ||
| CCR9 | chemokine (C-C motif) receptor 9 | 0.065 | Human | |
| IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.061 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.061 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.061 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.060 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.060 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.059 | Human | |
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.058 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.054 | Human | |
| ACVR2B | activin A receptor, type IIB | 0.053 | ||
| DNM1 | dynamin 1 | 0.053 | ||
| CCR8 | chemokine (C-C motif) receptor 8 | 0.053 | Human | |
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.050 | Human | |
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.048 | ||
| NRP1 | neuropilin 1 | 0.047 | ||
| KCTD1 | potassium channel tetramerisation domain containing 1 | 0.045 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.045 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.044 | ||
| IL1F5 | interleukin 1 family, member 5 (delta) | 0.043 | ||
| FOXF2 | forkhead box F2 | 0.042 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.041 | ||
| GDNF | glial cell derived neurotrophic factor | 0.040 | ||
| IL4 | interleukin 4 | 0.039 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.039 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.039 | ||
| TLX1 | T-cell leukemia homeobox 1 | 0.038 | ||
| INHBA | inhibin, beta A | 0.038 | ||
| PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.038 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.037 | ||
| ALB | albumin | 0.036 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.036 | Human | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.036 | ||
| SH3BP4 | SH3-domain binding protein 4 | 0.035 | ||
| APP | amyloid beta (A4) precursor protein | 0.035 | ||
| FGF18 | fibroblast growth factor 18 | 0.034 | ||
| SMAD9 | SMAD family member 9 | 0.034 | ||
| IL21R | interleukin 21 receptor | 0.034 | ||
| IDE | insulin-degrading enzyme | 0.034 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.034 | ||
| HDAC9 | histone deacetylase 9 | 0.034 | ||
| CCR6 | chemokine (C-C motif) receptor 6 | 0.033 | Human | |
| MEF2A | myocyte enhancer factor 2A | 0.033 | ||
| ESR1 | estrogen receptor 1 | 0.033 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.033 | ||
| MYOD1 | myogenic differentiation 1 | 0.032 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.032 | ||
| SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 0.032 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.031 | Human | |
| COL2A1 | collagen, type II, alpha 1 | 0.030 | ||
| IL6R | interleukin 6 receptor | 0.030 | ||
| TNF | tumor necrosis factor | 0.030 | ||
| SMAD6 | SMAD family member 6 | 0.030 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.029 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.029 | ||
| IL1A | interleukin 1, alpha | 0.028 | ||
| SNAPIN | SNAP-associated protein | 0.028 | ||
| SOX1 | SRY (sex determining region Y)-box 1 | 0.028 | ||
| HAND2 | heart and neural crest derivatives expressed 2 | 0.028 | Human | |
| EBI3 | Epstein-Barr virus induced 3 | 0.027 | ||
| UBR4 | ubiquitin protein ligase E3 component n-recognin 4 | 0.026 | ||
| PLA2G2D | phospholipase A2, group IID | 0.026 | ||
| MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.026 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.026 | Human | |
| CCL20 | chemokine (C-C motif) ligand 20 | 0.026 | Human | |
| LTB | lymphotoxin beta (TNF superfamily, member 3) | 0.025 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.025 | ||
| PDCD1 | programmed cell death 1 | 0.025 | ||
| CD86 | CD86 molecule | 0.025 | ||
| EPHB2 | EPH receptor B2 | 0.025 | ||
| TCF12 | transcription factor 12 | 0.025 | ||
| PTEN | phosphatase and tensin homolog | 0.024 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.024 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.024 | ||
| NEUROG2 | neurogenin 2 | 0.024 | Human | |
| IL18RAP | interleukin 18 receptor accessory protein | 0.024 | ||
| FGF3 | fibroblast growth factor 3 | 0.023 | ||
| IL13 | interleukin 13 | 0.022 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.022 | ||
| RUNX2 | runt-related transcription factor 2 | 0.022 | ||
| FZD7 | frizzled homolog 7 (Drosophila) | 0.022 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.022 | ||
| TBX21 | T-box 21 | 0.021 | ||
| SHOX2 | short stature homeobox 2 | 0.021 | ||
| GABARAPL1 | GABA(A) receptor-associated protein like 1 | 0.021 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.020 | ||
| CD80 | CD80 molecule | 0.020 | ||
| IL7R | interleukin 7 receptor | 0.020 | ||
| LAG3 | lymphocyte-activation gene 3 | 0.020 | ||
| SELE | selectin E | 0.020 | ||
| CXCR2 | chemokine (C-X-C motif) receptor 2 | 0.020 | Human | |
| WIF1 | WNT inhibitory factor 1 | 0.019 | ||
| IHH | Indian hedgehog | 0.019 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.019 | ||
| CCL21 | chemokine (C-C motif) ligand 21 | 0.019 | ||
| FPR3 | formyl peptide receptor 3 | 0.019 | ||
| FOXF1 | forkhead box F1 | 0.019 | ||
| SIX6 | SIX homeobox 6 | 0.019 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.019 | ||
| MMP19 | matrix metallopeptidase 19 | 0.018 | ||
| INSR | insulin receptor | 0.018 | ||
| PITPNM3 | PITPNM family member 3 | 0.018 | ||
| EFS | embryonal Fyn-associated substrate | 0.018 | ||
| EVI2B | ecotropic viral integration site 2B | 0.018 | ||
| GAS1 | growth arrest-specific 1 | 0.018 | ||
| NELL1 | NEL-like 1 (chicken) | 0.018 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.018 | ||
| IL11 | interleukin 11 | 0.018 | ||
| HEYL | hairy/enhancer-of-split related with YRPW motif-like | 0.018 | ||
| HTR4 | 5-hydroxytryptamine (serotonin) receptor 4 | 0.018 | ||
| ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.018 | ||
| PRKACB | protein kinase, cAMP-dependent, catalytic, beta | 0.018 | ||
| FOXB1 | forkhead box B1 | 0.018 | ||
| DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.018 | ||
| CLEC7A | C-type lectin domain family 7, member A | 0.018 | ||
| HOXC8 | homeobox C8 | 0.017 | ||
| SOD3 | superoxide dismutase 3, extracellular | 0.017 | ||
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.017 | ||
| ALX4 | ALX homeobox 4 | 0.017 | ||
| LNX1 | ligand of numb-protein X 1 | 0.017 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.017 | ||
| FGF4 | fibroblast growth factor 4 | 0.017 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.017 | Human | |
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.017 | ||
| NRP2 | neuropilin 2 | 0.017 | ||
| CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | 0.017 | ||
| EGFL6 | EGF-like-domain, multiple 6 | 0.017 | ||
| DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.017 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.016 | ||
| DARC | Duffy blood group, chemokine receptor | 0.016 | ||
| SLC9A3 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 | 0.016 | ||
| EFNB3 | ephrin-B3 | 0.016 | ||
| CD83 | CD83 molecule | 0.016 | ||
| ZIC3 | Zic family member 3 (odd-paired homolog, Drosophila) | 0.016 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.016 | Human | |
| IL2RG | interleukin 2 receptor, gamma | 0.016 | ||
| LGALS2 | lectin, galactoside-binding, soluble, 2 | 0.016 | ||
| MUC1 | mucin 1, cell surface associated | 0.015 | ||
| PHOX2A | paired-like homeobox 2a | 0.015 | ||
| MSC | musculin | 0.015 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.015 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.015 | ||
| KLF1 | Kruppel-like factor 1 (erythroid) | 0.015 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.015 | ||
| RUNX3 | runt-related transcription factor 3 | 0.015 | ||
| AHR | aryl hydrocarbon receptor | 0.015 | ||
| HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B | 0.015 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.015 | ||
| SMAD4 | SMAD family member 4 | 0.015 | ||
| FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.015 | ||
| AQP5 | aquaporin 5 | 0.015 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.014 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.014 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.014 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.014 | ||
| ACVR1B | activin A receptor, type IB | 0.014 | Human | |
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.014 | ||
| FEV | FEV (ETS oncogene family) | 0.014 | ||
| PRRX2 | paired related homeobox 2 | 0.014 | ||
| RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.014 | ||
| DUOX1 | dual oxidase 1 | 0.014 | ||
| WISP1 | WNT1 inducible signaling pathway protein 1 | 0.014 | ||
| ACTL8 | actin-like 8 | 0.014 | ||
| FGF10 | fibroblast growth factor 10 | 0.014 | ||
| C2 | complement component 2 | 0.014 | ||
| WISP2 | WNT1 inducible signaling pathway protein 2 | 0.014 | ||
| ADRB3 | adrenergic, beta-3-, receptor | 0.014 | ||
| ROR2 | receptor tyrosine kinase-like orphan receptor 2 | 0.014 | ||
| C11orf10 | chromosome 11 open reading frame 10 | 0.014 | ||
| DHH | desert hedgehog | 0.013 | ||
| USP15 | ubiquitin specific peptidase 15 | 0.013 | ||
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.013 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.013 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.013 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.013 | ||
| WNT7A | wingless-type MMTV integration site family, member 7A | 0.013 | Human | |
| NKX3-2 | NK3 homeobox 2 | 0.013 | ||
| SELPLG | selectin P ligand | 0.013 | ||
| LAMA5 | laminin, alpha 5 | 0.013 | ||
| BMP8B | bone morphogenetic protein 8b | 0.013 | Human | |
| ADCYAP1 | adenylate cyclase activating polypeptide 1 (pituitary) | 0.013 | ||
| IL9 | interleukin 9 | 0.013 | ||
| CH25H | cholesterol 25-hydroxylase | 0.013 | ||
| CCL17 | chemokine (C-C motif) ligand 17 | 0.013 | Human | |
| CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.013 | ||
| POU4F3 | POU class 4 homeobox 3 | 0.013 | ||
| TG | thyroglobulin | 0.013 | ||
| PLEK | pleckstrin | 0.013 | ||
| EIF2D | eukaryotic translation initiation factor 2D | 0.013 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.013 | ||
| DIO3 | deiodinase, iodothyronine, type III | 0.013 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.013 | ||
| HMX1 | H6 family homeobox 1 | 0.013 | ||
| XCR1 | chemokine (C motif) receptor 1 | 0.013 | Human | |
| FGF21 | fibroblast growth factor 21 | 0.013 | ||
| HIC1 | hypermethylated in cancer 1 | 0.013 | ||
| TCF4 | transcription factor 4 | 0.013 | ||
| PDX1 | pancreatic and duodenal homeobox 1 | 0.012 | ||
| PITX2 | paired-like homeodomain 2 | 0.012 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.012 | ||
| NPAS1 | neuronal PAS domain protein 1 | 0.012 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.012 | ||
| HAS2 | hyaluronan synthase 2 | 0.012 | ||
| ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.012 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.012 | ||
| GABRB1 | gamma-aminobutyric acid (GABA) A receptor, beta 1 | 0.012 | ||
| FZD10 | frizzled homolog 10 (Drosophila) | 0.012 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.012 | ||
| PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 0.012 | ||
| AQP9 | aquaporin 9 | 0.012 | ||
| SSX4 | synovial sarcoma, X breakpoint 4 | 0.012 | ||
| PF4 | platelet factor 4 | 0.012 | ||
| OAF | OAF homolog (Drosophila) | 0.012 | ||
| HEMGN | hemogen | 0.012 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.011 | ||
| CBFA2T3 | core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | 0.011 | ||
| CDCP1 | CUB domain containing protein 1 | 0.011 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.011 | Human | |
| SCRT1 | scratch homolog 1, zinc finger protein (Drosophila) | 0.011 | ||
| DLX4 | distal-less homeobox 4 | 0.011 | ||
| HDAC4 | histone deacetylase 4 | 0.011 | ||
| CYP19A1 | cytochrome P450, family 19, subfamily A, polypeptide 1 | 0.011 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.011 | ||
| PRPH | peripherin | 0.011 | ||
| ARRB1 | arrestin, beta 1 | 0.011 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.011 | ||
| CD160 | CD160 molecule | 0.011 | ||
| ZIC1 | Zic family member 1 (odd-paired homolog, Drosophila) | 0.011 | ||
| GSC2 | goosecoid homeobox 2 | 0.011 | ||
| CYP11B2 | cytochrome P450, family 11, subfamily B, polypeptide 2 | 0.011 | Human | |
| VSX1 | visual system homeobox 1 | 0.011 | ||
| NEUROG1 | neurogenin 1 | 0.011 | Human | |
| TCF21 | transcription factor 21 | 0.011 | ||
| POU4F2 | POU class 4 homeobox 2 | 0.011 | ||
| LY96 | lymphocyte antigen 96 | 0.011 | ||
| CD48 | CD48 molecule | 0.011 | ||
| SPOCK2 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 | 0.011 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.011 | ||
| HOXD11 | homeobox D11 | 0.011 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.011 | ||
| VAX1 | ventral anterior homeobox 1 | 0.011 | ||
| INHBB | inhibin, beta B | 0.011 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.011 | ||
| FBLN1 | fibulin 1 | 0.011 | ||
| ITGB8 | integrin, beta 8 | 0.011 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.011 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.011 | ||
| FOXD3 | forkhead box D3 | 0.011 | ||
| SLURP1 | secreted LY6/PLAUR domain containing 1 | 0.011 | ||
| HES2 | hairy and enhancer of split 2 (Drosophila) | 0.011 | ||
| HOXD13 | homeobox D13 | 0.010 | ||
| ICOSLG | inducible T-cell co-stimulator ligand | 0.010 | ||
| KREMEN2 | kringle containing transmembrane protein 2 | 0.010 | ||
| TBC1D10A | TBC1 domain family, member 10A | 0.010 | ||
| GJD2 | gap junction protein, delta 2, 36kDa | 0.010 | ||
| TSHB | thyroid stimulating hormone, beta | 0.010 | ||
| BMP6 | bone morphogenetic protein 6 | 0.010 | ||
| ACAN | aggrecan | 0.010 |